The Burden of Irritable Bowel Syndrome and Functional Dyspepsia in Poland: A Cross- Sectional Study from West Pomeranian Voivodship
Authors:
Preprint
- 22 October 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Functional gastrointestinal disorders (FGIDs), now known as disorders of gut-brain interaction (DGBIs), such as Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD), significantly impact global health, reducing quality of life and burdening healthcare systems. This study addresses the epidemiological gap in Poland, focusing on the West Pomeranian Voivodeship. Methods We conducted a cross-sectional study of 2070 Caucasian patients (58.2% female, mean age 57.5 ± 15.1 years) undergoing gastrointestinal endoscopic examinations at Pomeranian Medical University from 2021 to 2023. Data were collected using Rome IV diagnostic questionnaires and correlated with gastroduodenoscopy and colonoscopy findings. Exclusion criteria were age under 18, pregnancy, Crohn’s disease, ulcerative colitis, severe comorbidities, cancer, immunosuppressive therapy, ileostomy/colostomy, incomplete questionnaires, or lack of consent. Results Using Rome IV criteria, IBS was diagnosed in 436 participants (21.1%) and FD in 248 participants (12.0%). Post-endoscopic evaluation revised FD diagnoses to 184 individuals (8.9%). Females had a higher prevalence of IBS and FD (OR 1.64 and 1.61, respectively). No significant association was found between higher BMI and increased risk of IBS and FD. Hypertension and diabetes prevalence were 35.1% and 13.0%, respectively. Individuals with a history of COVID-19 had a higher risk of developing IBS (OR 1.47, P = 0.050). Conclusions Our study provides crucial epidemiological data on IBS and FD in Poland, emphasizing the importance of endoscopic evaluations. Our findings highlight the need for regional studies to understand local DGBI prevalence, aiding targeted healthcare strategies.Keywords
All Related Versions
- Version 1, 2024-10-22, Research Square
- Published version: BMC Gastroenterology, 25 (1), 1.
This publication has 36 references indexed in Scilit:
- Prolonged Gastrointestinal Manifestations After Recovery From COVID-19Clinical Gastroenterology and Hepatology, 2023
- Overlap of disorders of gut–brain interaction: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2023
- The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care CostsClinical Gastroenterology and Hepatology, 2023
- Evidence-based clinical practice guidelines for functional dyspepsia 2021Journal of Gastroenterology, 2022
- Diagnostic yield of endoscopy in irritable bowel syndrome: A nationwide prevalence study 1987–2016European Journal of Internal Medicine, 2021
- United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsiaUnited European Gastroenterology Journal, 2021
- Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2020
- Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based studyThe Lancet Gastroenterology & Hepatology, 2018
- ACG and CAG Clinical Guideline: Management of DyspepsiaAmerican Journal of Gastroenterology, 2017
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysisClinical Gastroenterology and Hepatology, 2012